4//SEC Filing
KENYON LAWRENCE A 4
Accession 0001415889-24-008974
CIK 0001649989other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 5:00 PM ET
Size
5.8 KB
Accession
0001415889-24-008974
Insider Transaction Report
Form 4
KENYON LAWRENCE A
CFO and Secretary
Transactions
- Award
Stock Option (Right to Buy)
2024-03-20+12,500→ 12,500 totalExercise: $6.78Exp: 2034-03-20→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on March 20, 2025, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. The option is also subject to acceleration under certain circumstances.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001230484
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 5:00 PM ET
- Size
- 5.8 KB